Navigation Links
MRSA study suggests strategy shift needed to develop effective therapeutics
Date:3/17/2009

USA300the major epidemic strain of methicillin-resistant Staphylococcus aureus (MRSA) causing severe infections in the United States during the past decadeinherits its destructiveness directly from a forefather strain of the bacterium called USA500 rather than randomly acquiring harmful genes from other MRSA strains. This finding comes from a new study led by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The study authors suggest that a radical shift may be needed in how scientists should design MRSA therapeutics. Instead of the current focus on neutralizing MRSA by targeting products of mobile genetic elementsDNA molecules that bacteria acquire randomly by interacting with other bacteriascientists should switch to looking at the permanent DNA backbone (core genome) of USA300 to understand how increased production of certain proteins such as toxins affects its virulence in humans.

NIAID scientist Michael Otto, Ph.D., directed the study, which involved analyzing DNA sequences of the major epidemic forms of S. aureus. The research team found that the lineage of the bacteria fell into three distinct families: (1) USA300 and its forefather, USA500, which are epidemic in U.S. hospital and community settings; (2) MRSA found primarily in hospitals in the United Kingdom and Europe; and (3) MRSA found in hospitals in South America, Europe and Asia.

The researchers then tested the different lineages in mice, observing that the USA300 and USA500 strains were significantly more destructive than the other strains. Further, when interacting with human immune cells, the USA300 and USA500 strains killed nearly 80 percent of the immune cells, compared with a rate of less than 10 percent for all other strains tested. Finally, when the scientists evaluated what in the bacteria was killing the immune cells, they found that levels of alpha toxin and alpha-type phenol-soluble modulins (PSMs) were significantly higher in USA300 and USA500 compared with the other strains. Earlier NIAID studies determined that alpha toxin and alpha-type PSMs play a crucial role in determining the severity of community-associated MRSA infection.

Another important finding of the study, according to Dr. Otto, is that USA300 and USA500 are nearly identical in virulence, as is their level of virulence gene production. This suggests that the Panton-Valentine leukocidin (PVL) and other mobile genetic elements long believed to play key roles in USA300 virulence have no significant impact, because while USA300 carries the PVL and other mobile genes, USA500 does not.


'/>"/>

Contact: Ken Pekoc
kpekoc@niaid.nih.gov
406-375-9690
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. Study tracks increasing use of CT on pregnant women
2. First sister study results reinforce the importance of healthy living
3. Tens of Thousands of Back Pain Patients Overtreated in Six Health Plans, According to HealthCore Study
4. Study Finds that Dying Patients and Families Suffer from Lack of Continuity of Physician Care
5. New Clinical Study Finds Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Accurate in the Noninvasive Monitoring of Fluid Status During Surgery
6. Firefighters Have Narrower-Than-Normal Arteries, Study Finds
7. Drugs Before Stents for Stable Heart Disease, Study Says
8. New Study Shows Probiotic Strain Effective in Boosting Immune Response
9. Studying the female form
10. Aspirin improves survival in women with stable heart disease, according to WHI study
11. New Study Finds PFOA Levels in Drinking Water Are Safe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ... 2017 , ... Sensogram Technologies Inc., the world leader in ... week at HIMSS 2017 Conference & Exhibition. The event brings more than 40,000 ... featured in the conference’s Connected Health Experience section, an area specifically designed for ...
(Date:2/20/2017)... ... , ... Johns Hopkins All Children's Hospital celebrated a major milestone with the ... marked the halfway point of construction and lifting of the final beam on the ... a center for innovation aimed at finding new discoveries and treatments for childhood diseases. ...
(Date:2/19/2017)... ... 2017 , ... The Citadel’s new Swain Department of Nursing , along ... Joseph, Ph.D. Joseph was engaged by the college as a consultant to help build ... After a nation-wide search, she was selected to head the department as nurse administrator, ...
(Date:2/19/2017)... (PRWEB) , ... February 19, 2017 , ... ... solutions for connected home healthcare, will join forces with Healthwise ® at ... education. Healthwise, the industry leader in evidence-based health education, technology and services, ...
(Date:2/18/2017)... Hills, California (PRWEB) , ... February 17, 2017 ... ... info@drvallecillos.com , drvallecillos.com , Beverly Hills plastic surgeon Dr. ... subcutaneous fat cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... Seal Shield LLC ( Jacksonville, FL ... device management and disinfection, the ElectroClave™, to the exhibit ... Orlando, Fla. from February 20-23, ... become commonplace in today,s healthcare landscape, but with this ... including the disinfection and tracking of these devices.  The ...
(Date:2/20/2017)... 20, 2017  There has been a paradigm shift ... across sub-Saharan Africa, which in turn is driving the ... more Western lifestyle diseases such as cardiovascular disease (CVD), ... and parasitic illness, will present the pharmaceutical industry in ... of $40.8 billion in 2019. "An increase ...
(Date:2/20/2017)... FRANCISCO , February 20, 2017 ... management market  is anticipated to reach USD 1.4 ... by Grand View Research, Inc. Constant evaluation of ... management is expected to drive growth in this ... investment for development of novel and improved shunts ...
Breaking Medicine Technology: